Mental Status Schedule

• 

  Subject Areas on Research

  • A multidisciplinary approach in the evaluation of demented drivers referred to geriatric assessment centers. 
  • AGTR1 gene variation: association with depression and frontotemporal morphology. 
  • APOE genotype and hippocampal volume change in geriatric depression. 
  • Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. 
  • Alternative statistical approaches to identifying dementia in a community-dwelling sample. 
  • An abbreviated Mini-Mental State Exam for medically ill older adults. 
  • An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study. 
  • Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men. 
  • Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. 
  • Apolipoprotein E-epsilon 4 frequency in geriatric depression. 
  • Ascending digits task as a measure of executive function in geriatric depression. 
  • Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients. 
  • Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. 
  • Association of silent lacunar infarct with brain atrophy and cognitive impairment. 
  • Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam. 
  • Canadian study of health and aging: study methods and prevalence of dementia. 
  • Canonical feature selection for joint regression and multi-class identification in Alzheimer's disease diagnosis. 
  • Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. 
  • Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia. 
  • Characteristics of nonresponders in a community survey of the elderly. 
  • Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. 
  • Clinically significant depressive symptoms and associated factors in community elderly subjects from Sao Paulo, Brazil. 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. 
  • Cognitive screening tests: an aid in the care of elderly outpatients. 
  • Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. 
  • Comparison of two brief tests of organic brain impairment, the MSQ and the short portable MSQ. 
  • Deciding for Others 
  • Dementia assessment and management. 
  • Depression in late life. 
  • Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls. 
  • Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults. 
  • Differences between depressed patients with heart failure and those with pulmonary disease. 
  • Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data. 
  • Does this patient have delirium?: value of bedside instruments. 
  • Does this patient have dementia? 
  • Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. 
  • Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. 
  • Equivalence of two screens of cognitive functioning: the Short Portable Mental Status Questionnaire and the Orientation-Memory-Concentration test. 
  • Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory. 
  • Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. 
  • Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts. 
  • Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. 
  • Getting meaningful informed consent from older adults: a structured literature review of empirical research. 
  • Hippocampal atrophy confounds template-based functional MR imaging measures of hippocampal activation in patients with mild cognitive impairment. 
  • Hippocampal volume and incident dementia in geriatric depression. 
  • Hippocampal volume is associated with physician-reported acute cognitive deficits after electroconvulsive therapy. 
  • Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. 
  • Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability. 
  • Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. 
  • Is medication use by community-dwelling elderly people influenced by cognitive function? 
  • Life events, mental health functioning and the use of health care services by the elderly. 
  • Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric. 
  • Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations. 
  • Mortality and cognitive status among elderly Canadians living in the community and in institutions: the Canadian Study of Health and Aging. 
  • Observations on pain and suffering. 
  • Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. 
  • Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model. 
  • Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. 
  • Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. 
  • Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia. 
  • Presence of and correction for interviewer error on an instrument assessing cognitive function of older adults. 
  • Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline. 
  • Profile of depressive symptoms in younger and older medical inpatients with major depression. 
  • Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. 
  • Reduction of dorsolateral prefrontal cortex gray matter in late-life depression. 
  • Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly. 
  • Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. 
  • Religion, spirituality, and health in medically ill hospitalized older patients. 
  • Religious coping in the nursing home: a biopsychosocial model. 
  • Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. 
  • Scoring nonresponse on the Mini-Mental State Examination. 
  • Statistical impact of truncated sampling or alteration of administration: the case of the Geriatric Depression Scale. 
  • TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype. 
  • Telephone adaptation of the Modified Mini-Mental State Exam (3MS). The Cache County Study. 
  • The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. 
  • The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The Neurobehavioral Cognitive Status Examination: psychometric properties in use with psychiatric inpatients. 
  • The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. 
  • The construct validity of the ischemic score of Hachinski for the detection of dementias. 
  • The effect of major depression on functional status in patients with coronary artery disease. 
  • The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. 
  • The prevalence and 3-year incidence of dementia in older Black and White community residents. 
  • Topiramate-induced confusion following a single ingestion of 400 mg. 
  • Translation of clinical and neuropsychological instruments into French: the CERAD experience. 
  • Validity of pain behaviors in persons with mild to moderate cognitive impairment. 
  • Vitamin D levels and cognition in elderly adults in China. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology